Market Overview:
The global COVID-19 diagnostics market is currently experiencing strong growth. COVID-19 diagnostics refer to the clinical tests conducted to detect the presence of the viral infection among individuals. COVID-19 is an infectious disease caused by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat and body aches. The viral infection is usually diagnosed through reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing. These tests use reagents and kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP) and nasal swabs, human saliva or blood. They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.
The sudden outbreak of coronavirus disease and an alarming increase in the number of COVID-19 cases across the globe are among the key factors creating a positive outlook for the market growth. The continuous rise in the number of daily cases has led to the widespread adoption of diagnostic tests for rapid and comprehensive testing to provide early treatment to the patients. In line with this, the increasing demand for mass testing and molecular diagnostics is contributing to the market growth. Additionally, various product innovations, such as the launch of novel antibody and serology test kits for home-testing, are acting as other growth-inducing factors. In comparison to the traditionally used testing kits, these variants are less time-consuming and can be integrated with software-based programs for accurate results. Other factors, including the implementation of favorable government polices to prevent the further spread of COVID-19 infection, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market growth. Looking forward, IMARC Group expects the global COVID-19 diagnostics market to continue its strong growth during the next five years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global COVID-19 diagnostics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product type, sample type, test type, mode and end use.
Breakup by Product Type:
- Reagents and Kits
- Instruments
- Others
Breakup by Sample Type:
- Nasopharyngeal Swabs
- Oropharyngeal Swabs
- Nasal Swabs
- Blood
- Others
Breakup by Test Type:
- Molecular (RT-PCR) Testing
- Antigen-based Testing
- Antibody (Serology) Testing
- Others
Breakup by Mode:
- Point-of-Care (PoC)
- Non-Point-of-Care (Non-PoC)
Breakup by End Use:
- Laboratories
- Hospitals
- Diagnostic Centers and Clinics
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
- How has the global COVID-19 diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global COVID-19 diagnostics market?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the sample type?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the mode?
- What is the breakup of the market based on the end use?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global COVID-19 diagnostics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global COVID-19 Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Reagents and Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Sample Type
7.1 Nasopharyngeal Swabs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oropharyngeal Swabs
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Nasal Swabs
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Blood
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Test Type
8.1 Molecular (RT-PCR) Testing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Antigen-based Testing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Antibody (Serology) Testing
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Mode
9.1 Point-of-Care (PoC)
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Non-Point-of-Care (Non-PoC)
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by End Use
10.1 Laboratories
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Hospitals
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Diagnostic Centers and Clinics
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Becton Dickinson and Company
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 bioMérieux SA
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Bio-Rad Laboratories
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Danaher Corporation
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 F. Hoffman-La Roche Ltd. (Roche Holding AG)
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 Luminex Corporation
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 PerkinElmer Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Quest Diagnostics Incorporated
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Robert Bosch GmbH
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Seegene Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.12 Siemens Aktiengesellschaft
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Thermo Fisher Scientific Inc.
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
16.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: COVID-19 Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: COVID-19 Diagnostics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: COVID-19 Diagnostics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: COVID-19 Diagnostics Market: Breakup by Product Type (in %), 2020
Figure 5: Global: COVID-19 Diagnostics Market: Breakup by Sample Type (in %), 2020
Figure 6: Global: COVID-19 Diagnostics Market: Breakup by Test Type (in %), 2020
Figure 7: Global: COVID-19 Diagnostics Market: Breakup by Mode (in %), 2020
Figure 8: Global: COVID-19 Diagnostics Market: Breakup by End Use (in %), 2020
Figure 9: Global: COVID-19 Diagnostics Market: Breakup by Region (in %), 2020
Figure 10: Global: COVID-19 Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: COVID-19 Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: COVID-19 Diagnostics (Instruments) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: COVID-19 Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: COVID-19 Diagnostics (Other Product Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: COVID-19 Diagnostics (Other Product Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: COVID-19 Diagnostics (Nasopharyngeal Swabs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: COVID-19 Diagnostics (Nasopharyngeal Swabs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: COVID-19 Diagnostics (Oropharyngeal Swabs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: COVID-19 Diagnostics (Oropharyngeal Swabs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: COVID-19 Diagnostics (Nasal Swabs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: COVID-19 Diagnostics (Nasal Swabs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: COVID-19 Diagnostics (Blood) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: COVID-19 Diagnostics (Blood) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: COVID-19 Diagnostics (Other Sample Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: COVID-19 Diagnostics (Other Sample Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: COVID-19 Diagnostics (Molecular/RT-PCR Testing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: COVID-19 Diagnostics (Molecular/RT-PCR Testing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: COVID-19 Diagnostics (Antigen-based Testing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: COVID-19 Diagnostics (Antigen-based Testing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: COVID-19 Diagnostics (Antibody Testing- Serology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: COVID-19 Diagnostics (Antibody Testing- Serology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: COVID-19 Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: COVID-19 Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: COVID-19 Diagnostics (Point-of-Care- PoC) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: COVID-19 Diagnostics (Point-of-Care- PoC) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Global: COVID-19 Diagnostics (Non-Point-of-Care- Non-PoC) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Global: COVID-19 Diagnostics (Non-Point-of-Care- Non-PoC) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Global: COVID-19 Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Global: COVID-19 Diagnostics (Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Global: COVID-19 Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Global: COVID-19 Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Global: COVID-19 Diagnostics (Diagnostic Centers and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Global: COVID-19 Diagnostics (Diagnostic Centers and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Global: COVID-19 Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Global: COVID-19 Diagnostics (Other End Uses) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: North America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: North America: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: United States: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: United States: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Canada: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Canada: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Asia-Pacific: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Asia-Pacific: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: China: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: China: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Japan: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Japan: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: India: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: India: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: South Korea: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: South Korea: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Australia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Australia: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Indonesia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Indonesia: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Others: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Europe: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Europe: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Germany: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Germany: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: France: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: France: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: United Kingdom: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: United Kingdom: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Italy: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Italy: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Spain: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Spain: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Russia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Russia: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Others: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Latin America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 85: Latin America: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 86: Brazil: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 87: Brazil: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 88: Mexico: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 89: Mexico: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 90: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 91: Others: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 92: Middle East and Africa: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2015 & 2020
Figure 93: Middle East and Africa: COVID-19 Diagnostics Market: Breakup by Country (in %), 2020
Figure 94: Middle East and Africa: COVID-19 Diagnostics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 95: Global: COVID-19 Diagnostics Industry: SWOT Analysis
Figure 96: Global: COVID-19 Diagnostics Industry: Value Chain Analysis
Figure 97: Global: COVID-19 Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: COVID-19 Diagnostics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: COVID-19 Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 3: Global: COVID-19 Diagnostics Market Forecast: Breakup by Sample Type (in Million US$), 2021-2026
Table 4: Global: COVID-19 Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2021-2026
Table 5: Global: COVID-19 Diagnostics Market Forecast: Breakup by Mode (in Million US$), 2021-2026
Table 6: Global: COVID-19 Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2021-2026
Table 7: Global: COVID-19 Diagnostics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 8: Global: COVID-19 Diagnostics Market: Competitive Structure
Table 9: Global: COVID-19 Diagnostics Market: Key Players